Wedbush Morgan Maintains an 'Outperform' on Nektar Therapeutics (NKTR); Raises Price Target

Go back to Wedbush Morgan Maintains an 'Outperform' on Nektar Therapeutics (NKTR); Raises Price Target
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 74.55 -1.53 (2.01%)
Previous Close $76.08    52 Week High $19.98 
Open $76.08    52 Week Low $10.52 
Day High $76.53    P/E N/A 
Day Low $74.55    EPS $-1.45 
Volume 51,015